Communication planning and pharmaceutical publications programs
Integrated programs to support product commercialization and market education
Pharmaceutical communications
PAREXEL Medical Communications translates science and data to communications that promote action - action that can help transform medical knowledge and practice. Our expertise in evidence-based communications and our transparent, compliant working processes set us apart as a medical communications company.
Three decisive factors fuel our expertise:
- Our ability to understand complex data and contribute innovative scientific and clinical insights
- Our flair to see things from new and different angles
- Our commitment to implement ideas with passion and enthusiasm
This combination makes the vital difference to ensure that a brand's unique medical profile is clearly communicated and understood by all stakeholders, in order to deliver optimal business results.
Pharmaceutical publications planning
Sponsors’ research data are their key strategic asset, and we help them maximize the evidence base for their products through our world-class publication planning and management services.
Whether you require a small plan for a single drug indication or extensive plans for multiple products or indications, our approach ensures successful planning and high-quality implementation. In fact, in 2009 we achieved a first-time acceptance rate of over 90%.
The communications strategy and/or publications plan sets out our recommendations for dissemination of data and expert opinions via abstracts, primary manuscripts, meta-analyses, reviews, posters, symposia, speaker presentations, and many other medical education activities. All tactical elements of a plan are related back to the messages they support for comprehensive coverage of key educational objectives.